Skip to main content
NASDAQ:ANIK

Anika Therapeutics News Headlines

$42.20
-0.37 (-0.87 %)
(As of 05/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$40.47
$43.22
50-Day Range
$34.00
$42.82
52-Week Range
$27.53
$47.47
Volume104,580 shs
Average Volume136,546 shs
Market Capitalization$607.30 million
P/E RatioN/A
Dividend YieldN/A
Beta1.1

Headlines

Anika Therapeutics (NASDAQ ANIK) News Headlines Today

SourceHeadline
Anika Therapeutics (NASDAQ:ANIK) Issues  Earnings ResultsAnika Therapeutics (NASDAQ:ANIK) Issues Earnings Results
americanbankingnews.com - May 7 at 5:04 PM
Anika Therapeutics, Inc. 2021 Q1 - Results - Earnings Call PresentationAnika Therapeutics, Inc. 2021 Q1 - Results - Earnings Call Presentation
seekingalpha.com - May 7 at 11:27 AM
Anika Therapeutics Inc (ANIK) Q1 2021 Earnings Call TranscriptAnika Therapeutics Inc (ANIK) Q1 2021 Earnings Call Transcript
finance.yahoo.com - May 7 at 9:37 AM
BRIEF-Anika Therapeutics Q1 Adjusted Earnings Per Share $0.06BRIEF-Anika Therapeutics Q1 Adjusted Earnings Per Share $0.06
msn.com - May 6 at 6:36 PM
Anika Therapeutics (NASDAQ:ANIK) Shareholders Have Enjoyed A 19% Share Price GainAnika Therapeutics (NASDAQ:ANIK) Shareholders Have Enjoyed A 19% Share Price Gain
nasdaq.com - May 5 at 7:32 AM
Reviewing Anika Therapeutics (NASDAQ:ANIK) and CVR Medical (OTCMKTS:CRRVF)Reviewing Anika Therapeutics (NASDAQ:ANIK) and CVR Medical (OTCMKTS:CRRVF)
americanbankingnews.com - May 4 at 8:30 AM
ANIK: Lowering target price to $37.00ANIK: Lowering target price to $37.00
finance.yahoo.com - April 30 at 12:38 AM
Anika Therapeutics (ANIK) Scheduled to Post Earnings on ThursdayAnika Therapeutics (ANIK) Scheduled to Post Earnings on Thursday
americanbankingnews.com - April 29 at 3:18 AM
Osteoarthritis Therapeutic Market to Witness Huge Growth by 2025 | Sanofi, Horizon Therapeutics, Johnson & JohnsonOsteoarthritis Therapeutic Market to Witness Huge Growth by 2025 | Sanofi, Horizon Therapeutics, Johnson & Johnson
marketwatch.com - April 27 at 8:48 AM
Lip Augmentation Market 2021 Production, Revenue, Growth Rate, Price and Gross Margin, Opportunities and Forecast 2027 with Top Growth CompaniesLip Augmentation Market 2021 Production, Revenue, Growth Rate, Price and Gross Margin, Opportunities and Forecast 2027 with Top Growth Companies
marketwatch.com - April 23 at 6:50 PM
ANIK: Rating decreased to a SELLANIK: Rating decreased to a SELL
finance.yahoo.com - April 22 at 10:22 PM
Anika to Issue First Quarter 2021 Financial...Anika to Issue First Quarter 2021 Financial...
benzinga.com - April 17 at 7:43 AM
Anika to Issue First Quarter 2021 Financial Results on Thursday, May 6, 2021Anika to Issue First Quarter 2021 Financial Results on Thursday, May 6, 2021
finance.yahoo.com - April 15 at 6:00 PM
Artificial Cartilage Implant Market 2021 Booming Strategies of Top Companies, Progression Status and Business Trends to 2031Artificial Cartilage Implant Market 2021 Booming Strategies of Top Companies, Progression Status and Business Trends to 2031
marketwatch.com - April 9 at 7:11 AM
Hemostats Market Sparkling Key Players Revenue, Shares, Analysis and Forecasts to 2027Hemostats Market Sparkling Key Players Revenue, Shares, Analysis and Forecasts to 2027
marketwatch.com - April 9 at 7:11 AM
Anika Therapeutics: Primed To Outperform The Market, Says Top BloggerAnika Therapeutics: Primed To Outperform The Market, Says Top Blogger
finance.yahoo.com - March 30 at 5:29 PM
Anika Therapeutics (ANIK) Presents At Sidoti Virtual Spring Investor Conference - SlideshowAnika Therapeutics (ANIK) Presents At Sidoti Virtual Spring Investor Conference - Slideshow
seekingalpha.com - March 26 at 7:27 PM
Osteoarthritis therapeutics is expected to grow at a CAGR of around 7.7% from 2020 to 2027 | ARCOsteoarthritis therapeutics is expected to grow at a CAGR of around 7.7% from 2020 to 2027 | ARC
marketwatch.com - March 9 at 8:24 AM
Analysts Have Been Trimming Their Anika Therapeutics, Inc. (NASDAQ:ANIK) Price Target After Its Latest ReportAnalysts Have Been Trimming Their Anika Therapeutics, Inc. (NASDAQ:ANIK) Price Target After Its Latest Report
nasdaq.com - March 6 at 8:10 AM
Anika Therapeutics, Inc. (NASDAQ:ANIK) Just Reported, And Analysts Assigned A US$47.50 Price TargetAnika Therapeutics, Inc. (NASDAQ:ANIK) Just Reported, And Analysts Assigned A US$47.50 Price Target
finance.yahoo.com - March 6 at 8:10 AM
Osteoarthritis Therapeutics Market Size Surpass Around USD 11.5 Billion by 2027Osteoarthritis Therapeutics Market Size Surpass Around USD 11.5 Billion by 2027
marketwatch.com - March 5 at 6:18 PM
Anika Therapeutics, Inc. 2020 Q4 - Results - Earnings Call PresentationAnika Therapeutics, Inc. 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 5 at 2:16 PM
Anika Therapeutics Inc (ANIK) Q4 2020 Earnings Call TranscriptAnika Therapeutics Inc (ANIK) Q4 2020 Earnings Call Transcript
fool.com - March 4 at 10:44 PM
Recap: Anika Therapeutics Q4 EarningsRecap: Anika Therapeutics Q4 Earnings
benzinga.com - March 4 at 7:29 PM
Heres what to expect from Anika Therapeuticss earningsHere's what to expect from Anika Therapeutics's earnings
markets.businessinsider.com - March 2 at 1:35 PM
Anika Therapeutics Inc. hosts conference call for investorsAnika Therapeutics Inc. hosts conference call for investors
markets.businessinsider.com - February 20 at 7:51 PM
Anika to Issue Fourth Quarter and Year-End 2020 Financial Results on Thursday, March 4, 2021Anika to Issue Fourth Quarter and Year-End 2020 Financial Results on Thursday, March 4, 2021
finance.yahoo.com - February 9 at 3:28 PM
Anika to Issue Fourth Quarter and Year-End 2020 Financial Results on Thursday, March 4, 2021Anika to Issue Fourth Quarter and Year-End 2020 Financial Results on Thursday, March 4, 2021
benzinga.com - February 9 at 3:09 PM
Medical Aesthetics Market Size Worth USD 38,850.89 Million by 2027 at 8.30% CAGR, Asserts Market Research Future (MRFR)Medical Aesthetics Market Size Worth USD 38,850.89 Million by 2027 at 8.30% CAGR, Asserts Market Research Future (MRFR)
marketwatch.com - February 8 at 9:10 AM
Technavio Research: COVID-19 Impacts and Recovery | Osteoarthritis Therapeutics Market Research 2020-2024 | TechnavioTechnavio Research: COVID-19 Impacts and Recovery | Osteoarthritis Therapeutics Market Research 2020-2024 | Technavio
finanznachrichten.de - February 3 at 10:53 PM
Osteoarthritis Therapeutics Market Overview, Trends, Growth Insights, Revenue, Sales, Company Analysis and Forecast 2020-2027Osteoarthritis Therapeutics Market Overview, Trends, Growth Insights, Revenue, Sales, Company Analysis and Forecast 2020-2027
marketwatch.com - January 24 at 3:47 AM
An Intrinsic Calculation For Anika Therapeutics, Inc. (NASDAQ:ANIK) Suggests Its 28% UndervaluedAn Intrinsic Calculation For Anika Therapeutics, Inc. (NASDAQ:ANIK) Suggests It's 28% Undervalued
finance.yahoo.com - December 30 at 8:15 AM
Anika Therapeutics (ANIK) Surges: Stock Moves 6.6% HigherAnika Therapeutics (ANIK) Surges: Stock Moves 6.6% Higher
finance.yahoo.com - December 21 at 11:35 AM
Global Osteoarthritis Therapeutics Market is Growing at a CAGR of 8.9% by 2027Global Osteoarthritis Therapeutics Market is Growing at a CAGR of 8.9% by 2027
marketwatch.com - December 18 at 8:35 AM
Anika Therapeutics Inc. OutperformAnika Therapeutics Inc. Outperform
markets.businessinsider.com - December 17 at 10:32 PM
Osteoarthritis Therapeutics Market Size, CAGR, Trends, Consumption, Revenue, Company Analysis and Forecast 2020-2027Osteoarthritis Therapeutics Market Size, CAGR, Trends, Consumption, Revenue, Company Analysis and Forecast 2020-2027
marketwatch.com - December 17 at 7:30 AM
PEEK Fasteners Market Report 2020 Growth Factors, Product Type, Manufacturers, Application, End User and Regions 2026PEEK Fasteners Market Report 2020 Growth Factors, Product Type, Manufacturers, Application, End User and Regions 2026
marketwatch.com - November 21 at 11:34 PM
News for Anika Therapeutics Inc.News for Anika Therapeutics Inc.
markets.businessinsider.com - November 16 at 6:25 PM
Independent Director Raymond Land Just Sold A Bunch Of Shares In Anika Therapeutics, Inc. (NASDAQ:ANIK)Independent Director Raymond Land Just Sold A Bunch Of Shares In Anika Therapeutics, Inc. (NASDAQ:ANIK)
nasdaq.com - November 16 at 8:14 AM
Anika Therapeutics, Inc. (ANIK) CEO Cheryl Blanchard on Q3 2020 Results - Earnings Call TranscriptAnika Therapeutics, Inc. (ANIK) CEO Cheryl Blanchard on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 4 at 10:23 PM
Anika Therapeutics (ANIK) Reports Q3 Loss, Lags Revenue EstimatesAnika Therapeutics (ANIK) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 4 at 10:23 PM
Anika Therapeutics Inc (ANIK) Q3 2020 Earnings Call TranscriptAnika Therapeutics Inc (ANIK) Q3 2020 Earnings Call Transcript
finance.yahoo.com - November 4 at 10:23 PM
Anika Therapeutics EPS beats by $0.06, beats on revenueAnika Therapeutics EPS beats by $0.06, beats on revenue
seekingalpha.com - November 4 at 5:21 PM
Anika Therapeutics, Inc. to Host Earnings CallAnika Therapeutics, Inc. to Host Earnings Call
finance.yahoo.com - November 4 at 5:21 PM
Anika Reports Third-Quarter 2020 Financial ResultsAnika Reports Third-Quarter 2020 Financial Results
finance.yahoo.com - November 4 at 5:21 PM
Anika to Issue Third Quarter 2020 Financial Results and Business Highlights on Wednesday, November 4, 2020Anika to Issue Third Quarter 2020 Financial Results and Business Highlights on Wednesday, November 4, 2020
finance.yahoo.com - October 22 at 6:31 PM
FDA OKs Anika wrist restoration deviceFDA OKs Anika wrist restoration device
seekingalpha.com - October 21 at 7:08 PM
Anika Therapeutics, Inc. (ANIK)Anika Therapeutics, Inc. (ANIK)
ca.finance.yahoo.com - October 1 at 12:30 PM
ANIK vs. ILMN: Which Stock Should Value Investors Buy Now?ANIK vs. ILMN: Which Stock Should Value Investors Buy Now?
nasdaq.com - September 24 at 1:14 PM
Anika Announces Appointment of Jack Henneman and Stephen Richard to Board of DirectorsAnika Announces Appointment of Jack Henneman and Stephen Richard to Board of Directors
finance.yahoo.com - September 8 at 6:58 PM
This page was last updated on 5/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.